2XXH
Crystal structure of 1-(4-(2-oxo-2-(1-pyrrolidinyl)ethyl)phenyl)-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole in complex with the ligand binding domain of the Rat GluA2 receptor and glutamate at 1.5A resolution.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF |
Synchrotron site | ESRF |
Temperature [K] | 100 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 114.374, 163.583, 47.481 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 20.000 - 1.500 |
R-factor | 0.19487 |
Rwork | 0.194 |
R-free | 0.21757 |
Structure solution method | OTHER |
Starting model (for MR) | NONE |
RMSD bond length | 0.009 |
RMSD bond angle | 1.344 |
Refinement software | REFMAC (5.5.0109) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 30.000 | 1.580 |
High resolution limit [Å] | 1.500 | 1.500 |
Rmerge | 0.070 | 0.390 |
Number of reflections | 134500 | |
<I/σ(I)> | 11.4 | 2.6 |
Completeness [%] | 94.8 | 96.5 |
Redundancy | 2.8 | 2.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 |